← Back to Blog

New Study Finds Centenarians Have Gut Bacteria That Counter Age-Related Inflammation

A team at UC San Diego published findings in Cell Metabolism this week showing that people who reach 100 share a distinctive gut microbiome pattern. Their gut bacteria modify bile acids in a way that may push back against the metabolic decline and low-grade inflammation that accumulates with age.

Written by Sydney Murphy, CMO & Digital Products Officer. Reviewed by the Sensa Wellness editorial team. Written to reflect current, publicly available inflammation research.

The short answer

Yes, there is a real pattern. Researchers at UC San Diego found that centenarians carry gut bacteria with elevated bile salt hydrolase (BSH) activity, an enzyme that breaks down conjugated bile acids into forms that appear to support metabolic health. Aged mice engineered to have higher BSH activity in the gut showed improved insulin sensitivity and better body composition. The finding suggests that some age-related changes in the gut microbiome may actually be protective rather than harmful. It does not mean there is a simple pill or probiotic fix yet, but it opens a genuinely interesting new line of research into how the gut microbiome interacts with the low-grade chronic inflammation that tends to build up over decades.

Scientists have known for years that the gut microbiome shifts as we age, and the conventional view has been that most of those shifts are bad. Microbial diversity drops, beneficial species become less abundant, and the gut lining grows more permeable, letting bacterial products seep into circulation and contributing to what researchers now call inflammaging, the slow, smoldering background inflammation that underlies many conditions of later life. That narrative is not wrong, but new research published November 16 in Cell Metabolism adds an important nuance: at least one class of microbial changes in exceptionally old adults appears to be doing something useful, not harmful.

The source article, covered by News-Medical.net on November 16, 2026, describes work led by Dr. Amir Zarrinpar at UC San Diego. The team compared gut microbiome activity across three age groups: 48 young adults, 107 older adults, and 125 centenarians. The centenarians stood out in one specific way: their gut bacteria showed higher activity of an enzyme called bile salt hydrolase, and their overall bile acid profile reflected more deconjugation of taurine-conjugated bile acids than the other groups.

Bile acid deconjugation is a process where gut bacteria cleave the amino acid taurine or glycine from bile acids produced by the liver. This converts conjugated bile acids into unconjugated forms that interact differently with the body's receptors, signaling pathways, and inflammatory responses.

What the Study Actually Found

The core finding is that aged mice and human centenarians share a bile acid signature suggesting elevated bile salt hydrolase activity. In mice, the researchers confirmed this directly: older animals showed higher transcriptional activity of BSH-related genes and more deconjugated bile acids in their intestinal contents compared with younger animals. When the team then engineered gut bacteria to amplify this BSH activity in aged mice, the animals showed improved insulin sensitivity, alongside supportive changes in body composition and other metabolic measures. The effects were not dramatic, but they were consistent and statistically significant.

The human data came from reanalysis of publicly available aging cohort datasets that included bile acid measurements. Centenarians had higher ratios of unconjugated bile acids compared with both younger adults and older adults who had not reached exceptional longevity. They also showed more BSH-related gene expression in their gut microbiome data. This parallel between the mouse experiments and the human observational data is what makes the study notable. It is unusual to see the same mechanistic signature in a mouse model and in one of the best-characterized human longevity populations simultaneously.

The authors are careful to frame this as an association rather than proof of cause. Centenarians may carry this bile acid signature because it helps them live longer, or they may carry it because of decades of diet and lifestyle habits that produced both the signature and the longevity. It is also possible that this pattern is a downstream marker of something else entirely. What the study does firmly establish is that this microbiome activity is worth studying further as a potential lever for healthy aging.

Why Bile Acids Connect to Inflammation

Bile acids are not just digestive fluids for processing fat. They are signaling molecules that reach receptors throughout the body. Two of the most important are the farnesoid X receptor (FXR), found in the liver, intestine, and immune cells, and the Takeda G protein-coupled receptor 5 (TGR5), found in immune cells, the gut lining, and metabolic tissues. Both of these receptors respond differently to conjugated versus unconjugated bile acids, and both have direct connections to inflammatory signaling.

Activation of FXR and TGR5 by specific bile acid forms tends to suppress inflammatory gene expression. FXR activation, for example, has been shown to inhibit NF-kappaB, the master transcription factor that turns on the production of pro-inflammatory cytokines including IL-6 and TNF-alpha. TGR5 activation in macrophages reduces the same signals. This means the form and ratio of bile acids circulating in the body is not biochemically neutral. Changes driven by gut bacteria that shift the balance toward certain unconjugated species can, in theory, reduce the background level of inflammatory signaling at a systemic level.

This mechanism is part of a broader picture of how the gut microbiome influences whole-body inflammation. Short-chain fatty acids, another class of microbial metabolites produced from dietary fiber, have a well-documented anti-inflammatory effect through similar receptor-based signaling. The UC San Diego findings suggest bile acids represent a parallel and previously underappreciated pathway through which gut bacteria modulate systemic inflammation. As a 2026 review in Nutrients noted, gut microbiota-targeted approaches to healthy aging that work through metabolite production represent a biologically plausible framework with growing mechanistic support, even if clinical translation is still early (Kryczyk-Poprawa et al., 2026).

The Inflammaging Context

To understand why this research matters, it helps to know what inflammaging actually means. As the body ages, the immune system does not simply slow down. It enters a state of persistent, low-level activation that researchers call inflammaging, a portmanteau of inflammation and aging. Circulating levels of IL-6, TNF-alpha, and CRP gradually rise over decades even in the absence of infection or injury. This chronic background inflammation has been linked to virtually every major age-related condition, from cardiovascular disease and type 2 diabetes to Alzheimer's disease, sarcopenia, and functional decline.

The gut is one of the most important drivers of this process. An aging gut lining becomes more permeable, allowing lipopolysaccharide (LPS) fragments from gram-negative bacteria to cross into circulation. LPS is one of the most potent activators of Toll-like receptor 4, which in turn fires off the NF-kappaB pathway and raises CRP and other acute-phase proteins. Reductions in microbial diversity mean fewer species producing short-chain fatty acids that keep the gut lining tight and immune cells in check. The UC San Diego study adds to this picture by showing that at least in some long-lived individuals, the microbiome shifts to produce a bile acid profile that may partially offset these pro-inflammatory tendencies.

A 2026 review in Frontiers in Microbiomes described this dynamic using the framework of a diet-microbiota-host gene triad. As organisms age, this equilibrium destabilizes, leading to reduced microbial diversity, compromised barrier integrity, and chronic inflammation that accelerates age-related pathologies (Bhattacharjee and Mukhopadhyay, 2026). The centenarian findings suggest that some individuals maintain or develop a microbiome configuration that pushes back against this trajectory, though exactly how or why that happens in some people and not others is still an open question.

What It Means in Practice (and What It Does Not Mean)

The honest answer to "how can I apply this" is that the science is not there yet. Bile salt hydrolase is expressed by dozens of bacterial species across multiple genera, including Lactobacillus, Bifidobacterium, Bacteroides, and Clostridium species. You cannot take a pill of BSH enzyme and expect it to replicate what gut bacteria do in a living system. And the engineered bacteria used in the mouse experiments are research tools, not consumer products. This is early-stage mechanistic work, and the path from "centenarians have this microbial pattern" to "here is a proven intervention that replicates it" involves many more steps.

What the research does support is the broader case for maintaining a diverse, well-nourished gut microbiome throughout life. The dietary patterns most consistently associated with higher microbial diversity and beneficial metabolite production, including bile acid profiles that support receptor signaling, are ones that emphasize plant foods, fiber, fermented foods, and limited ultra-processed foods. Polyphenol-rich foods, including berries, olive oil, nuts, and legumes, have particular relevance because polyphenols are metabolized by gut bacteria into bioactive forms that influence both bile acid processing and inflammatory pathways. None of this is new advice, but the centenarian microbiome data gives it another layer of mechanistic grounding.

Time-restricted eating and caloric restriction are also worth noting in this context. The Cell Metabolism study itself mentions both interventions in its opening, noting that they improve lifespan and aging-associated metabolic health partly through effects on the gut microbiome and bile acid dynamics. If those interventions work in part by shaping the same BSH-driven bile acid deconjugation signature seen in centenarians, that would be a significant insight into their mechanism of action and could eventually guide more targeted approaches.

CRP as a Window Into This Process

One practical implication of the inflammaging research broadly is that C-reactive protein offers a usable signal of where your inflammatory baseline sits. CRP is produced by the liver in response to IL-6, which in turn rises in proportion to the level of chronic background inflammatory activity. Because it reflects the net output of everything driving inflammation in the body, including gut-derived LPS, cytokines from visceral fat, and the other pathways involved in inflammaging, it tracks changes in that background even when no acute illness is present.

The lifestyle variables that most directly shape the gut microbiome also have documented effects on CRP. Increased dietary fiber, fermented food consumption, regular physical activity, weight management, and reduced ultra-processed food intake all move CRP in a favorable direction in well-designed trials. Tracking CRP over time gives you a composite readout of whether the changes you are making are shifting your inflammatory biology in the right direction, something no single food or supplement can tell you on its own. For anyone curious about their own numbers, Sensa measures CRP at home using a saliva sample, with no needle or clinic visit required. As always, persistent elevations in CRP are worth discussing with a healthcare provider.

Sources

  • Dantas Machado AC, Zhong W, Saran AR, et al. Microbial bile acid deconjugation counters metabolic decline in aging. Cell Metabolism, 2026. pubmed.ncbi.nlm.nih.gov/43038987
  • Kryczyk-Poprawa A, Rząsa-Duran E, Varga JT, et al. Gut Microbiota-Targeted Nutrition for Healthy Aging: Mechanistic Roles of Polyphenols and Dietary Fiber in Geroscience. Nutrients, 2026. pubmed.ncbi.nlm.nih.gov/42588100
  • Bhattacharjee S, Mukhopadhyay A. From cooperation to collapse: the diet-microbiota-host gene triad in disease and aging. Frontiers in Microbiomes, 2026. pubmed.ncbi.nlm.nih.gov/42602462
  • Grajeda-Iglesias C, Durand S, Daillere R, et al. Oral administration of Akkermansia muciniphila elevates systemic antiaging and anticancer metabolites. Aging (Albany NY), 2021. pubmed.ncbi.nlm.nih.gov/33653967
Share this article

Frequently Asked Questions

What did the centenarian gut bacteria study find?

A UC San Diego team published findings in Cell Metabolism (November 2026) showing that centenarians carry gut bacteria with elevated bile salt hydrolase (BSH) activity. This enzyme converts conjugated bile acids into unconjugated forms that interact with receptors linked to lower inflammatory signaling and better metabolic health. Aged mice engineered to have higher gut BSH activity showed improved insulin sensitivity and body composition, suggesting the signature has functional effects rather than just being a passive marker.

Can gut bacteria actually reduce inflammation?

Yes, through several well-documented mechanisms. Gut bacteria produce metabolites including short-chain fatty acids and modified bile acids that activate receptors in the gut lining and immune cells, dampening inflammatory signaling. When gut microbial diversity drops or barrier integrity breaks down, the opposite happens: more bacterial products reach the bloodstream and raise markers like CRP. The centenarian findings add bile acid deconjugation to the list of ways gut microbes may help contain age-related inflammation.

How does diet affect the gut microbiome and inflammation?

Diet is the single most modifiable driver of gut microbial composition. Diets high in dietary fiber, polyphenols, and fermented foods support microbial diversity and the production of anti-inflammatory metabolites including short-chain fatty acids and certain bile acid forms. Ultra-processed foods, diets low in plant variety, and excess added sugar do the opposite. The lifestyle variables associated with lower CRP levels overlap substantially with those that support a healthy gut microbiome.

Can I test my inflammation at home?

Yes. C-reactive protein (CRP) is the standard marker used in research on inflammaging and gut-microbiome-driven inflammation. Sensa measures CRP from a saliva sample at home, with no needle or clinic visit required, giving you a general wellness readout of your current inflammatory baseline. Tracking it over time lets you see whether dietary and lifestyle changes are moving the needle. Any persistently elevated reading is worth discussing with a healthcare provider.

Want to track your inflammation at home?

Sensa is a general wellness tool that lets you measure your CRP levels at home. No needles, no clinic visit. Track trends over time and make more informed lifestyle choices.

Buy Now

Get inflammation insights in your inbox

New articles on inflammation science, plus updates on the Sensa at-home CRP test and app.